...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM
1
Mar 22, 2024 03:10PM

Koo

Last years Zenith financials for 3rd Qtr ended 1/31/23 were released 4/6/23

Also should soon get news on RVX debenture which matures 5/13/24

2022 extension was reported 04/19/22

2023 extension was reported 03/20/23

What will this year bring? It's about time we received positive news

Chicagoest

2
Mar 22, 2024 03:46PM
1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply